OUR
RESEARCH
Our
research team led by Dr. Animesh A. Sinha at the New York
Presbyterian Hospital/ Weill Medical College of Cornell University
is undertaking a non-profit research project involving the genetics
of androgenetic alopecia (male-pattern baldness). This project, "Human
Gene Expression Mapping in Skin Disease," is supported in part by
grants from several non-profit organizations, and the study has been
given Institutional Review Board approval.
Our experimental
strategy is to use the most current molecular techniques to identify
and study the genes responsible for androgenetic alopecia. We will
analyze the expression of alopecia-related genes using "gene chips,"
a revolutionary technology that allows us to screen for thousands
of genetic sequences simultaneously. Ultimately, we wish to find the
links in the genome that render people susceptible to androgenetic
alopecia. It is our short-term goal to gain a better understanding
of why some individuals are pre-disposed to androgenetic alopecia
and to identify those individuals at risk. Over the long term, our
goal is to use this information to point us towards new and innovative
therapies for androgenetic alopecia.
HOW YOU
CAN HELP
We are
interested in recruiting patients who are afflicted with androgenetic
alopecia (male-pattern baldness). The success of our project is critically
dependent upon recruitment of eligible subjects. Your participation
is entirely voluntary, and would be greatly appreciated. Following
completion of an informed consent form, you will be asked to complete
a questionnaire concerning your medical history and your experience
with androgenetic alopecia. In addition, you will be asked to have
a skin biopsy performed at the New York Presbyterian Hospital at a
time that is convenient.
HOW
TO CONTACT US
If you have any questions or are interested in participating in the
study please call me, the study coordinator, Hadley King, at 212-746-6554,
or e-mail me at DermatologyResearch@med.cornell.edu.
I look forward to speaking with you in the near future.
